Oragenics, Inc. (OGEN) Financials

$0.18

north_east
$0.01 (4.18%)
Day's range
$0.17
Day's range
$0.18
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning2018201820192019202020202021202120222022202320232024202410000%10000%0%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%-60000%-60000%Profit Margin
Profit Margin
Revenue
Earnings

OGEN Income statement / Annual

Last year (2024), Oragenics, Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2024, Oragenics, Inc.'s net income was -$10.57 M. See Oragenics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $37,653.00 $131,521.00 $86,987.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.18 M
Cost of Revenue $0.00 $15.49 M $44,667.00 $41,237.00 $51,705.00 $62,622.00 $30,110.00 $65,803.00 $75,044.00 $481,743.00
Gross Profit $0.00 -$15.45 M $86,854.00 $45,750.00 -$51,705.00 -$62,622.00 -$30,110.00 -$65,803.00 -$75,044.00 $694,098.00
Gross Profit Ratio 0 -410.4 0.66 0.53 0 0 0 0 0 0.59
Research and Development Expenses $4.11 M $15.49 M $10.07 M $10.59 M $22.11 M $12.12 M $5.97 M $3.54 M $4.75 M $8.80 M
General & Administrative Expenses $6.44 M $5.45 M $4.47 M $5.27 M $4.53 M $3.76 M $4.02 M $3.18 M $3.79 M $3.54 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.44 M $5.45 M $4.47 M $5.27 M $4.53 M $3.76 M $4.02 M $3.18 M $3.79 M $3.54 M
Other Expenses $0.00 -$15.49 M $5,140.00 $1,357.00 $2,400.00 $1,601.00 $446.00 -$3,100.00 -$4,800.00 -$4,700.00
Operating Expenses $10.56 M $5.45 M $14.55 M $15.86 M $26.64 M $15.88 M $10.00 M $6.72 M $8.54 M $12.35 M
Cost And Expenses $0.00 $20.94 M $14.55 M $15.86 M $26.64 M $15.88 M $10.00 M $6.72 M $8.54 M $12.83 M
Interest Income $45,897.00 $179,803.00 $135,900.00 $75,847.00 $89,294.00 $320,011.00 $86,527.00 $10,221.00 $40,090.00 $21,378.00
Interest Expense -$29,828.00 $0.00 $15,103.00 $15,756.00 $10,685.00 $7,300.00 $5,786.00 $216,328.00 $4,116.00 $76,668.00
Depreciation & Amortization $38,931.00 $27,391.00 $44,667.00 $41,237.00 $51,705.00 $62,622.00 $30,110.00 $65,803.00 $75,044.00 $71,152.00
EBITDA -$10.56 M -$20.88 M -$14.23 M -$15.65 M -$26.37 M -$15.50 M -$9.88 M -$6.45 M -$8.42 M -$11.65 M
EBITDA Ratio 0 -554.47 -108.19 -179.97 0 0 0 0 0 -9.91
Operating Income Ratio 0 -555.2 -109.61 -181.3 0 0 0 0 0 -9.91
Total Other Income/Expenses Net -$9,103.00 $249,166.00 $127,239.00 $59,404.00 $210,757.00 $311,566.00 $79,999.00 -$13,207.00 $45,189.00 -$59,214.00
Income Before Tax -$10.57 M -$20.66 M -$14.29 M -$15.71 M -$26.43 M -$15.57 M -$9.91 M -$6.73 M -$8.50 M -$11.71 M
Income Before Tax Ratio 0 -548.58 -108.64 -180.62 0 0 0 0 0 -9.96
Income Tax Expense $0.00 $0.00 -$127,239.00 $16,426.00 $12,480.00 $7,756.00 -$79,999.00 $13,207.00 -$1.53 M $59,214.00
Net Income -$10.57 M -$20.66 M -$14.16 M -$15.73 M -$26.44 M -$15.57 M -$9.91 M -$6.73 M -$7.01 M -$11.71 M
Net Income Ratio 0 -548.58 -107.67 -180.81 0 0 0 0 0 -9.96
EPS -1.6 -9.18 -7.05 -8.36 -28.07 -22.1 -45.62 -81.99 -94.35 -191.7
EPS Diluted -1.6 -9.18 -7.05 -8.36 -28.07 -22.1 -45.62 -81.99 -94.33 -191.7
Weighted Average Shares Out $6.62 M $2.25 M $2.01 M $1.88 M $942,187.00 $704,732.00 $217,318.00 $82,104.00 $74,333.00 $61,093.00
Weighted Average Shares Out Diluted $6.62 M $2.25 M $2.01 M $1.88 M $942,187.00 $704,732.00 $217,318.00 $82,104.00 $74,348.00 $61,093.00
Link